海利生物：2025年前三季度归属于上市公司股东的净利润同比增长0.77%

Core Insights - The company reported a revenue of 149,742,032.70 yuan for the first three quarters of 2025, representing a year-on-year decline of 14.15% [2] - The net profit attributable to shareholders of the listed company was 20,329,681.80 yuan, showing a slight year-on-year increase of 0.77% [2] Financial Performance - Revenue for the first three quarters of 2025: 149.74 million yuan, down 14.15% year-on-year [2] - Net profit for the same period: 20.33 million yuan, up 0.77% year-on-year [2]